Healius Ltd
HLS · AU · Healthcare / Diagnostics & Research
0.575AUD+0.03 (+6.48%)
Price History
Full chartMarket Stats
Previous Close0.54
Open0.54
Day Range0.525 – 0.58
52-Week Range0.30 – 1.07
Volume8.16M
Market Cap286.84M
P/E (TTM)0.00
Forward P/E29.24
EPS-0.56
Dividend Yield0.00%
Beta0.29
50-Day Avg0.4152
200-Day Avg0.5447
About
Healius Limited provides medical laboratory and pathology services in Australia. The company provides services under the Laverty Pathology, Dorevitch Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics Pathology, QML Pathology, TML Pathology, Abbott Pathology, IQ Pathology, Kossard, Gastrolab Dermatopathology, and Agilex Biolabs brands. It operates medical laboratories and patient collection centers. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.
Company Details
- SectorHealthcare
- IndustryDiagnostics & Research
- CEOMr. Paul D. Anderson B.Com., C.A.
- Employees3.34K
- Headquarters161 Castlereagh Street, Sydney, NSW, Australia, 2000, Australia
- Websitehttps://www.healius.com.au
Leadership
- Mr. Paul D. Anderson B.Com., C.A.MD, CEO & Director
- Mr. Andrew ThomsonCFO & Company Secretary
- Mr. Puneet Nagi M.B.A.Chief Operating Officer
- Mr. Prasad AravGroup Executive of Digital & Technology and Strategy
- Sharon NgHead of FP&A and Investor Relations
- Ms. Kylie BrownGroup General Counsel, Company Secretary & Chief Risk Officer
- Ms. Paula BaylissGroup Executive of People & Culture
- Mr. John McKechnieAdvisor
- Dr. Phil LucasChief Executive of Lumus Imaging
- Ian McphanChief Operating Officer of Healius Pathology
Financials
Income Statement
Balance Sheet
Cash Flow
Earnings
Key Statistics & Ratios
Market Cap286.84M
Enterprise Value1.19B
Trailing P/E0.00
Forward P/E29.24
PEG Ratio1.60
Price / Sales0.21
Price / Book1.52
EPS-0.56
Book Value0.236
Revenue (TTM)1.37B
Gross Profit (TTM)428.20M
EBITDA59.80M
Profit Margin-30.27%
Operating Margin2.20%
Return on Equity-107.69%
Return on Assets1.18%
Shares Outstanding726.18M
Shares Float575.75M
Beta0.29
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%
Dividends
20251×
0.41May 9, 2025
20222×
0.06Sep 7, 20220.09Mar 24, 2022
20212×
0.06Sep 13, 20210.06Mar 25, 2021
20201×
0.02Mar 26, 2020
20192×
0.03Aug 29, 20190.04Mar 15, 2019
20182×
0.05Aug 27, 20180.05Mar 16, 2018
20172×
0.05Aug 31, 20170.04Mar 17, 2017
20162×
0.06Sep 1, 20160.05Mar 18, 2016
20152×
0.10Aug 26, 20150.08Mar 18, 2015
20142×
0.10Aug 27, 20140.08Mar 17, 2014
20132×
0.10Sep 16, 20130.07Mar 15, 2013
20122×
0.06Sep 14, 20120.05Mar 23, 2012
20112×
0.05Sep 16, 20110.03Mar 18, 2011
Stock Splits
- Aug 22, 2018511:493
- Feb 18, 2008348:247